Report the ad
Access Glofitamab Injection in Delhi India for DLBCL Care - Delhi
Tuesday, 11 March, 2025
Item details
City:
Delhi
Offer type:
Offer
Item description
Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) can benefit from Glofitamab Injection in India, a targeted therapy that helps activate the immune system to fight cancer cells. Impomed Healthcare facilitates access to this advanced treatment, ensuring reliable oncology solutions for those in need of effective care.
For more information visit: httpswww.impomedhealthcare.com
For more information visit: httpswww.impomedhealthcare.com